Expression of selected tumor suppressor and oncogenes in endometrium of women with endometriosis
article
OA: bronze
CC0
⤵ 48 in-corpus citations
AI-generated summary
This study found significantly higher AKT1 and 4EBP1 mRNA levels in the eutopic endometrium of women with endometriosis compared to controls.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: It is becoming increasingly evident that the eutopic endometrium of women with endometriosis shows certain genetic alterations which are not found in the endometrium of disease-free women. The aim of the study was to compare the expression level of mammalian target of rapamycin (mTOR) tumor suppressor and oncogene-related genes in the endometrium of women with and without endometriosis as well as in ovarian endometriosis. METHODS: A total of 81 regularly menstruating patients were recruited in the study. We applied the micro fluidic gene array to examine the expression of 15 human tumor suppressor and oncogenes in eutopic endometrium of 40 women with endometriosis and 41 controls without endometriosis. In 14 patients with endometriosis, gene expression was also studied in matched ovarian lesions. We studied the following genes: NF1, RHEB, mTOR, PTEN, TSC1, TSC2, KRAS, S6K1, TP53, EIF4E, LKB1, PIK3CA, BECN1, 4EBP1 and AKT1. Immunohistochemical studies were subsequently performed for selected proteins. RESULTS: Of the 15 studied genes, we found significantly higher levels of oncogene AKT1 (P = 0.006) and tumor suppressor gene 4EBP1 (P = 0.01) mRNAs in the eutopic endometrium of women with endometriosis compared with control patients. Immunohistochemistry showed that 4EBP1 and AKT1 proteins were expressed in eutopic endometrium. CONCLUSIONS: Our results suggest that up-regulation of AKT1 and 4EBP1 in eutopic endometrium may be associated with the pathogenesis of endometriosis, but their precise role remains to be established.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- Activation of mammalian target of rapamycin in postmenopausal ovarian endometriosis via openalex
- Dating the Endometrial Biopsy via openalex
- Endometriosis and ovarian cancer: Thoughts on shared pathophysiology via openalex
- Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis via openalex
- Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis via openalex
- Pathogenic mechanisms in endometriosis-associated infertility via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- W1978366541 via openalex
- W1998502987 via openalex
- W1971133173 via openalex
- W2050980183 via openalex
- W2056891806 via openalex
- W2060157525 via openalex
- W2077302626 via openalex
- W2100320756 via openalex
- W2107277218 via openalex
- W2118120822 via openalex
- W1545891414 via openalex
- W2134138119 via openalex
- W2144323242 via openalex
- W2156320420 via openalex
- W2204640292 via openalex
- W1487234933 via openalex
Cited by (48)
- Molecular mechanism of autophagy and apoptosis in endometriosis: Current understanding and future research directions 2024
- Association of Fibroids, Endometriosis, and Gynecologic Surgeries with Breast Cancer Incidence and Hormone Receptor Subtypes 2024
- Does the Use of the “Proseek® Multiplex Inflammation I Panel” Demonstrate a Difference in Local and Systemic Immune Responses in Endometriosis Patients with or without Deep-Infiltrating Lesions? 2023
- Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis 2023
- Autoantibody screening of plasma and peritoneal fluid of patients with endometriosis 2023
- Parthenolide repressed endometriosis induced surgically in rats: Role of PTEN/PI3Kinase/AKT/GSK-3β/β-catenin signaling in inhibition of epithelial mesenchymal transition 2023
- Peritoneal autoantibody landscape in endometriosis 2022
- Research into the mechanism of intervention of SanQi in endometriosis based on network pharmacology and molecular docking technology 2022
- Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC) 2022
- Roles of microRNAs in Regulating Apoptosis in the Pathogenesis of Endometriosis 2022
- The Eutopic Endometrium Proteome in Endometriosis Reveals Candidate Markers and Molecular Mechanisms of Physiopathology 2022
- The Role of mTOR and eIF Signaling in Benign Endometrial Diseases 2022
- Liriodendrin alleviates sciatic endometriosis-associated pain in rats via suppressing inflammatory response and regulating the signaling pathway of Pl3K/Akt/mToR 2021
- Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review 2020
- How Benign is Endometriosis: Multi-Scale Interrogation of Documented Evidence 2019
- Genetic variants in the nucleotide excision repair genes are associated with the risk of developing endometriosis 2019
- Lack of an Association between a Polymorphism in the KRAS 3′ Untranslated Region (rs61764370) and Endometriosis in a Large European Case-Control Study 2019
- Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis 2018
- Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development 2018
- Distinguishing the progression of an endometrioma: Benign or malignant? 2018
- MicroRNA expression profiling in endometriosis-associated infertility and its relationship with endometrial receptivity evaluated by ultrasound 2017
- Autophagy in endometriosis. 2017
- Endometrial biomarkers for the non-invasive diagnosis of endometriosis 2016
- Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics 2016
- PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors 2015
- Molecular Pathogenesis of Ovarian Clear Cell Carcinoma 2015
- The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 2015
- Profiling of Selected MicroRNAs in Proliferative Eutopic Endometrium of Women with Ovarian Endometriosis 2015
- K-Ras 4A Transcript variant is up-regulated in eutopic endometrium of endometriosis patients during proliferative phase of menstrual cycle 2014
- Altered Biological Characteristics of Eutopic and Ectopic Endometrium 2014
- Influence of AKT on Progesterone Action in Endometrial Diseases 2014
- Phosphatidylinositol-3 kinase-Akt-mammalian target of rapamycin signaling pathway mediates contractility of human endometriotic stromal cells: A promising new target for the treatment of endometriosis-associated fibrosis 2014
- Inhibition of epidermal growth factor receptor restores decidualization markers in stromal fibroblasts from women with endometriosis 2014
- Inflammation and ovarian cancer – current views 2013
- Determination of cathepsins B, D and G concentration in eutopic proliferative endometrium of women with endometriosis by the surface plasmon resonance imaging (SPRI) technique 2013
- Eutopic Endometrium in Women with Endometriosis: Ground Zero for the Study of Implantation Defects 2013
- Profiling of selected angiogenesis-related genes in proliferative eutopic endometrium of women with endometriosis 2013
- Aberrant Expression of the Mammalian Target of Rapamycin, Hypoxia-inducible Factor-1α, and Glucose Transporter 1 in the Development of Ovarian Clear-cell Adenocarcinoma 2012
- Chronic pelvic pain in menopausal women 2012
- Przewlek³y ból miednicy u kobiet w wieku menopauzalnym 2012
- PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update 2011
- The mTOR/AKT Inhibitor Temsirolimus Prevents Deep Infiltrating Endometriosis in Mice 2011
- Signaling Pathways in Endometriosis (Eutopic/Ectopic) 2011
- Increased Activation of the PI3K/AKT Pathway Compromises Decidualization of Stromal Cells from Endometriosis 2011
- Ovarian clear cell carcinoma—bad endometriosis or bad endometrium? 2011
- Endometriosis Gene Expression Heterogeneity and Biosignature: A Phylogenetic Analysis 2011
- Novel estrogen-related genes and potential biomarkers of ovarian endometriosis identified by differential expression analysis 2011
- Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis 2010
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:05.573375+00:00
License: CC0
· commercial use OK